°øÁö»çÇ×
¾÷·Îµå Áß ÀÔ´Ï´Ù. Àá½Ã¸¸ ±â´Ù·Á Áֽʽÿä...
À̸§
À̸ÞÀÏ
ºñ¹Ð¹øÈ£
¿É¼Ç
HTML MODE
Á¦¸ñ
³»¿ë
Recorded Delivery
ellipta vs spiriva
Matisi's troubles began in mid-2012, when a financial commentator posted a remark on an online bulleting board stating that shares of a Arena had "climbed high" because of a widespread belief that the Food and Drug Administration would approve an obesity drug the company developed. She also cited the cautionary Barron's article.
÷ºÎÆÄÀÏ